Redeye remains positive to STRAX following a strong Q4 where revenues came in as expected, but operating expenses were lower than expected. For 2021, we expect a recovery for the core business from Q2 and forward. We also expect the new Health and Wellness segment to show slight y/y growth, which makes us increase our estimates on revenues while we slightly reduce our estimates on margin.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

STRAX - Strong Comeback Expected

© Modular Finance, source Nordic Press Releases